5 Questions With… 2020 Recap

5 Questions With 2020
Published on :

In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.

2020’s Top 10 Most Read News Stories from the BioHealth Capital Region

Published on :

2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.

Meet Your 2020 BioBuzz Award Winners

Published on :

Today, we are excited to announce the winners of our inaugural BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.

Novavax is Building a Global Tech Transfer Team to Rapidly Deliver 2 Billion COVID-19 Vaccine Doses Around the World

Published on :

Gaithersburg, Maryland’s Novavax has skyrocketed to national and global prominence during the coronavirus pandemic. In an incredibly short time, the company has advanced its SARS-CoV-2 vaccine candidate into Phase III trials and received FDA fast track designation, putting its vaccine very close to potential FDA approval.

Announcing Finalists for 1st Annual BioBuzz Awards

Published on :

This year, more than ever before, we’ve seen just how important it is for us all to stay connected and work together to build a stronger biotech ecosystem. In the face of great adversity, the biotech community has risen to the challenge and formed new collaborations and partnerships to innovate and rapidly develop new medicines and tools to help us beat this pandemic.

Billions Pour into BioHealth Capital Region to Battle COVID-19

Published on :

Over the past nine months, more than $7 billion in federal funding has poured into the BioHealth Capital Region aimed at the battle against COVID-19 and has shown a spotlight on the broad impact biopharma life science companies and academic institutions are making in the fight against the pandemic.

Strengths of Our Region: Combating Infectious Diseases Forum Roundup

Published on :

Over the past nine months, more than $7 billion in federal money has poured into the BioHealth Capital Region in support of therapies, diagnostics, and vaccines against COVID-19. In that short time, the region has shown its importance in halting the spread of the ongoing pandemic.

Emergent Biosolutions Seeks Biomanufacturing Talent for Three Maryland Manufacturing Facilities at Forefront of COVID-19 Battle

Published on :

Maryland’s leading vaccine manufacturer, Emergent Biosolutions (Emergent) is a global biopharmaceutical company that has become a key player in the BioHealth Capital Region’s (BCHR) fight against COVID-19.